PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 118 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $144,000 | -5.3% | 49,843 | 0.0% | 0.02% | -17.4% |
| Q4 2021 | $152,000 | -56.4% | 49,843 | 0.0% | 0.02% | -8.0% |
| Q3 2021 | $349,000 | -30.8% | 49,843 | -9.2% | 0.02% | -39.0% |
| Q2 2021 | $504,000 | -5.4% | 54,901 | 0.0% | 0.04% | +127.8% |
| Q1 2021 | $533,000 | -66.5% | 54,901 | -64.6% | 0.02% | -74.3% |
| Q4 2020 | $1,589,000 | +186.8% | 154,901 | +182.1% | 0.07% | +75.0% |
| Q3 2020 | $554,000 | -3.3% | 54,901 | 0.0% | 0.04% | -13.0% |
| Q2 2020 | $573,000 | +23.8% | 54,901 | 0.0% | 0.05% | +31.4% |
| Q1 2020 | $463,000 | -88.1% | 54,901 | -87.6% | 0.04% | -94.4% |
| Q4 2019 | $3,884,000 | – | 443,953 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |